HealthInvest Partners’s Ionis Pharmaceuticals IONS Stock Holding History

HealthInvest Partners’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.9M	Buy	137,131 +109,258	+392%	+$8.22M	2.93%	12
2026 Q1	$9.4M	Sell	27,873 -64,504	-70%	-$5.09M	3.03%	11
2025 Q4	$7.31M	Buy	+92,377	New	+$6.96M	2.33%	15
2024 Q4	–	Sell	-82,691	Closed	-$3.31M	–	38
2024 Q3	$3.31M	Buy	82,691 +42,000	+103%	+$1.95M	1.56%	20
2024 Q2	$1.94M	Sell	40,691 -23,100	-36%	-$947K	1.18%	21
2024 Q1	$2.77M	Buy	63,791 +39,548	+163%	+$1.89M	1.68%	23
2023 Q4	$1.23M	Buy	+24,243	New	+$1.16M	0.96%	26

Other funds holding IONS

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

FISPB

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

WMA

West Michigan Advisors Holland, Michigan $455M AUM 31.82% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HealthInvest Partners's IONS Position: Q2 2026 in Review

HealthInvest Partners increased its Ionis Pharmaceuticals (IONS) stake by 392% in Q2 2026, buying an estimated $8.22M and bringing the position to 137,131 shares worth $10.9M. The position accounts for 2.93% of the portfolio, ranked #12.

HealthInvest Partners first reported a position in IONS in Q4 2023 and has held it in 7 quarters since. 104 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

HealthInvest Partners held 137,131 shares of Ionis Pharmaceuticals worth $10.9M as of Q2 2026.
HealthInvest Partners bought 109,258 Ionis Pharmaceuticals shares in Q2 2026, an estimated $8.22M.
Ionis Pharmaceuticals made up 2.93% of HealthInvest Partners's portfolio in Q2 2026, its #12 holding.
HealthInvest Partners first reported a position in Ionis Pharmaceuticals in Q4 2023 and has held it in 7 quarters since.
104 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.